P. Batchuluun

发表

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

A. Bourinbaiar, Marina G Tarakanovskaya, V. Borisova, 2017, Journal of hepatocellular carcinoma.

Interim results from ongoing Phase III placebo-controlled, randomized trial of hepcortespenlisimut-L for advanced hepatocellular carcinoma indication

A. Bourinbaiar, Marina G Tarakanovskaya, V. Borisova, 2020 .

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

A. Bourinbaiar, Marina G Tarakanovskaya, V. Borisova, 2017, Journal of hepatocellular carcinoma.